RBC Europe’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $729K | Hold |
|
|||||
|
2022
Q1 | $816K | Hold |
|
|||||
|
2021
Q4 | $848K | Buy |
|
|||||
|
2021
Q3 | $783K | Hold |
|
|||||
|
2021
Q2 | $703K | Sell |
|
|||||
|
2021
Q1 | $1.15M | Hold |
|
|||||
|
2020
Q4 | $1.06M | Hold |
|
|||||
|
2020
Q3 | $1.19M | Buy |
|
|||||
|
2020
Q2 | $1.07M | Sell |
|
|||||
|
2020
Q1 | $892K | Sell |
|
|||||
|
2019
Q4 | $1.35M | Hold |
|
|||||
|
2019
Q3 | $946K | Hold |
|
|||||
|
2019
Q2 | $853K | Buy |
|
|||||
|
2019
Q1 | $865K | Buy |
|
|||||
|
2018
Q4 | $639K | Buy |
|
|||||
|
2018
Q3 | $629K | Buy |
|
|||||
|
2018
Q2 | $708K | Buy |
|
|||||
|
2018
Q1 | $732K | Buy |
|
|||||
|
2017
Q4 | $699K | Sell |
|
|||||
|
2017
Q3 | $822K | Buy |
|